Lindsey
0009-0004-4827-9562
2 papers found
Refreshing results…
Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2
RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity acrossFGFR2Alterations and Resistance Mutations
Missing publications? Search for publications with a matching author name.